Paul R. Schneider
CIK: 0001455484
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZYME
Zymeworks Inc.
Officer
Discretionary Trading P&L
Holdings
About Schneider Paul R
Schneider Paul R (SEC CIK 0001455484) files insider reports with the SEC as EVP, General Counsel of Zymeworks Inc. (ZYME).
Signal8 holds 2 ownership filings by Schneider Paul R (1 Form 3, 1 Form 4), filed on May 15, 2026. Those filings report 2 transactions, the latest on May 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Schneider Paul R's filings is in MIDDLETOWN, DE.
Recent filings by Schneider Paul R
- May 13, 2026: Grants or awards of ZYME derivative securities (2 lines, Form 4, code A).
Other insiders filing for Zymeworks Inc. (ZYME)
- Schayowitz Adam, EVP, Head of R&D
- Hollywood Mark, EVP & Chief Operating Officer
- Platshon Scott, EVP, Chief Business Officer
- Stafford Kristin, EVP, Chief Financial Officer
- Mekan Sabeen, SVP & Chief Medical Officer
- Cherry Brian N, Director